PF-AtlasDrugs › TOBI

TOBI

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
Unity Health Toronto

Overview

TOBI is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

TOBI clinical trials

Explore related

Medical disclaimer. This page summarizes research about TOBI for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.